Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Candel Therapeutics, Inc. (CADL) had Weighted-Average Shares Outstanding (Diluted) of 31.68M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-55.18M |
|
-- |
|
-- |
|
$33.37M |
|
$-33.37M |
|
$-21.81M |
|
$-55.18M |
|
$-55.18M |
|
$-55.18M |
|
$-55.18M |
|
$-55.18M |
|
$-55.18M |
|
$-33.37M |
|
$-32.38M |
|
31.68M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
31.68M |
$-1.74 |
|
$-1.74 |
|
| Balance Sheet Financials | |
$103.80M |
|
$2.19M |
|
$3.06M |
|
$106.87M |
|
$37.53M |
|
$2.60M |
|
$3.01M |
|
$40.54M |
|
$66.33M |
|
$66.33M |
|
$66.33M |
|
46.81M |
|
| Cash Flow Statement Financials | |
$-27.02M |
|
$-0.02M |
|
$94.28M |
|
$35.68M |
|
$102.92M |
|
$67.24M |
|
$5.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.77 |
|
-- |
|
-- |
|
0.04 |
|
0.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-27.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-83.19% |
|
-83.19% |
|
-51.63% |
|
-80.05% |
|
$1.42 |
|
$-0.85 |
|
$-0.85 |
|